Start Date
February 1, 2019
Primary Completion Date
January 1, 2024
Study Completion Date
June 1, 2024
UT Southwestern Medical Center at Dallas, Dallas
Collaborators (1)
MedImmune LLC
INDUSTRY
University of Texas Southwestern Medical Center
OTHER